By reversibly inhibiting COX-1 and COX-2, NSAIDs inhibit the biochemical conversion of arachidonic acid to PGH2 which then prevents the downstream effects of prostanoids to prevent the inflammatory response and reduce pain signalling
metformin brand name
Glucophage, Glumetza, Riomet
metformin+sitagliptin brand name
Janumet
lisinopril + hydrochlorothiazide brand name
Zestoretic
triamterene + hydrochlorothiazide brand name
Maxzide
valsartan + hydrochlorothiazide brand name
Diovan HCT
aspirin indication
secondary preventionafter acute coronary syndrome
aspirin activity
irreversiblecompetitiveinhibitor
aspirin target
COX-1
aspirin target class and location
oxidoreductase enzyme in platelets
acetaminophen activity
reversiblecompetitiveinhibitor
acetaminophen target
COX-1, COX-2, COX-3
acetaminophen target class and location
oxidoreductase enzyme in platelets in SMCs (COX-1), parenchymalcells (COX-2), CNS (COX-3)
acetaminophen + codeine brand name
Tylenol #3
celecoxib brand name
Celebrex
celecoxib pharmacologic activity
reversiblecompetitiveinhibitor
celecoxib target
COX-2
celecoxib target class and location
oxidoreductaseenzyme in parenchymalcells
diclofenac brand name
Voltaren
diclofenac indication
pain
celecoxib drug class
NSAID, COX-2selective; analgesic, nonopioid
diclofenac drug class
NSAID; analgenic nonopioid
diclofenac target
COX-1 and COX-2
ibuprofen drug class
NSAID; analgesic, nonopioid
ibuprofen indication
pain
ibuprofen activity
reversiblecompetitveinhibtor
ibuprofen drug target
COX-1 and COX-2
ibuprofen target class and location
oxidoreductaseenzyme in platelets and SMCs (COX-1) and parenchymalcells (COX-2)
diclofenac target class and location
oxidoreductase enzyme in platelets and SMCs (COX-1) and parenchymalcells (COX-2)
meloxicam target class and location
oxidoreductase enzyme in platelets and SMCs (COX-1) and parenchymalcells (COX-2)